Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2025-08-18 00:00:00 ET · period of report 2025-08-14 · accession 0001870913-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-08-18 | 2025-08-14+ | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $88.25 | -100.0K | 531.9K | -16% | -$8.82M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-14 | S | D | 47,010 | $89.48 | 584,910 | I Held by Esjay LLC | — | — | (F1) The shares were sold in multiple trades at prices ranging from $88.20 to $90.11. The price reported above reflects the weighted average sales price. (F2) The reporting person holds voting and dispositive power over the shares held by Esjay LLC. |
| 2 | Common | Common Stock | 2025-08-15 | S | D | 52,990 | $87.15 | 531,920 | I Held by Esjay LLC | — | — | (F3) The shares were sold in multiple trades at prices ranging from $85.44 to $90.00. The price reported above reflects the weighted average sales price. (F2) The reporting person holds voting and dispositive power over the shares held by Esjay LLC. |